Neuren Pharmaceuticals Limited documents

Explore the latest documents from Neuren Pharmaceuticals Limited, including regulatory filings and corporate disclosures that offer insight into company performance and strategy. Use these resources to support informed investment decisions.

Description

Event date

Documents and forms

2025

Investor Presentation

Aug 26, 2025

Slides

H1 2025

Aug 26, 2025

Interim report

AGM 2025

May 27, 2025

Slides

Q1 2025

May 7, 2025

Interim report

43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 13, 2025

Slides

2024

H2 2024

Feb 28, 2025

Transcript

Slides

Interim report

Investor Presentation

Nov 15, 2024

Slides

Q3 2024

Nov 6, 2024

Interim report

Study Result

Oct 7, 2024

Press release

Q2 2024

Aug 27, 2024

Interim report

Investor Roadshow Presentation

Aug 19, 2024

Slides

Study Result

Aug 9, 2024

Press release

Slides

Study Result

May 27, 2024

Press release

Slides

2023

H2 2023

Feb 29, 2024

Annual report

Slides

Q4 2023

Jan 31, 2024

Interim report

Investor Presentation

Nov 6, 2023

Slides

Q3 2023

Oct 19, 2023

Interim report

H1 2023

Aug 28, 2023

Interim report

Slides

Q2 2023

Jul 31, 2023

Interim report

Investor Presentation

Jul 14, 2023

Slides

Q1 2023

Apr 28, 2023

Interim report

Investor Presentation

Mar 13, 2023

Slides

Investor Presentation

Mar 1, 2023

Slides

Investor Presentation

Feb 24, 2023

Slides

2022

H2 2022

Feb 23, 2023

Annual report

Q4 2022

Jan 30, 2023

Interim report

Investor Presentation

Oct 27, 2022

Slides

Q3 2022

Oct 27, 2022

Interim report

H1 2022

Aug 24, 2022

Interim report